Navigation Links
REP8839 in Medical News

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

Replidyne, Inc. today announced results from three Phase I trials studying REP8839, a novel topical antibiotic that has shown potent in vitro activity against major skin pathogens including methicillin-resistant S. aureus (MRSA). The results of the Phase I trials show that topically applie...

Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

...acillus anthracis (BA) Inhalation Post-Exposure Prophylaxis Model." rep8839 Presentation Thursday, September 20 at 10:00 AM, Room E253D: -- Poster F1-2116, titled "In vitro Activity of rep8839 against Pasteurella species and Other Fastidious Bacteria Isolated fro...
REP8839 in Medical Technology

Replidyne Provides Strategic Update

... inhibition program. As a result of prioritizing these preclinical programs, Replidyne has suspended the development of topical antibiotic rep8839 due to the additional investment required to optimize the formulation and the niche market opportunity. -- Development strategy for faropenem. R...

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

... of the Phase I trials show that topically applied rep8839 appears safe, well-tolerated and associated with l...hase II trials to study the safety and efficacy of rep8839 in patients with impetigo and other skin and wound infections." rep8839 was tested in three Phase I trials which collectiv...
REP8839 in Biological Technology

Replidyne Announces Second Quarter 2008 Results From Operations

...eplidyne's discovery research programs, primarily the C. difficile and DNA replication inhibition programs, offset by decreased expense related to the rep8839 program that was suspended in December 2007. Sales, general and administrative expenses for the second quarter of 2008 were $4.7 million compared to...

Replidyne Announces 2007 Fourth Quarter and Full Year Results

...lidyne's discovery research programs, primarily its C. difficile and inhibition of DNA replication programs offset by decreased expense related to the rep8839 program that was suspended in December 2007. Research and development expense was $43.3 million for the full year 2007 compared to $38.3 million in 20...
Other Tags
(Date:5/4/2015)... 2015 Ticket Down is a reputable source ... Arena in Columbia, South Carolina. Fans of Paul ... “Out There” tour which originally kicked off in 2013. The ... America and the legendary performer recently announced that he would ... Arena on June 21st, in Charlottesville, VA at John Paul ...
(Date:5/4/2015)... CCL, a top-ranked, global provider of leadership ... other leadership development consultancies. “The CCL Partner Network ... practitioners, expanding our capacity to drive results for individual ... Ryan, CCL President and CEO. , As soon as ... , it will schedule a one-on-one conference with a ...
(Date:5/4/2015)... 04, 2015 San Diego Fertility ... at their brand new, 13,700 square foot facility scheduled ... building will not only provide fertility treatment and services ... offer community and educational events to a number of ... located next door to their current Carmel Valley/Del Mar ...
(Date:5/4/2015)... 2015 Dr. Benjamin Stong of Kalos ... the latest non-surgical double-chin eliminator. Dr. Stong is ... in Atlanta to offer Kybella treatments . The ... specifically under the chin, promising to safely dissolve fat ... patients who sought immediate solutions for their double chin ...
(Date:5/4/2015)... Unlike some camps, the Nike Middle School Running Camps are ... to educate first and train second, with a significant amount of ... runners are building the knowledge base needed to have a long ... include Effort Based Training, Running Heroes, Running Vocabulary, and Why am ... is not a camp where kids come to run and train ...
Breaking Medicine News(10 mins):Health News:Paul McCartney Tickets at Colonial Life Arena in Columbia, SC: Ticket Down Slashes Paul McCartney Ticket Prices in Columbia, South Carolina at Colonial Life Arena 2Health News:The Center for Creative Leadership Is Partnering with Lead Star to Create the CCL Partner Network 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2
(Date:3/24/2015)... , March 24, 2015   NexID Biometrics ... with critical security-authentication needs, today announced the beginning of ... (FFD) solution. The company, based in ... at the three-day Connect:ID Expo, which began here today ... NexID said version 2.0 of its SDK boosts the ...
(Date:3/23/2015)... March 23, 2015  In the 2014 fiscal year, ... conviction losses. This figure accounts for a fraction of ... The Nilson Report, exceeds $11 billion globally. The polygraph ... a crime has occurred. Investor Mark Saint Juste ... Joe Paolella partnered to administer the test ...
(Date:3/20/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... the growing mobile commerce market, announces its biometric payment ... products featured in 2015 "I Want That" International CES ... on the DIY Network.   DIY,s "I ... , site of the 2015 International CES for a ...
Breaking Biology News(10 mins):NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3
Other Contents